During the past decade, Lovelace Scientific Resources conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 36 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lovelace Scientific Resources" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Evoke Pharma" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lovelace Scientific Resources" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Allied Research International" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Lovelace Scientific Resources" are "Rheumatoid Arthritis" (17 trials), "Arthritis, Rheumatoid" (5 trials), "Diabetic Gastroparesis" (3 trials), "Chronic Pain" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Lovelace Scientific Resources" in a lesser frequency.

Most popular intervention types in "Lovelace Scientific Resources" are "Drug" (46 trials), "Biological" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "BI 695501" (2 trials), "Fostamatinib disodium (R935788)" (2 trials), "GLPG0634" (2 trials) and "Metoclopramide Nasal Spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lovelace Scientific Resources" are 51 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lovelace Scientific Resources". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Lovelace Scientific Resources, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Lovelace Scientific Resources, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".